Inspire Medical Systems Inc. (INSP) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Inspire Medical Systems I...

    NYSE: INSP · Real-Time Price · USD
    81.65
    2.88 (3.66%)
    At close: Sep 11, 2025, 1:27 PM

    Inspire Medical Systems Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 53.51M -21.15M -44.88M -42.04M
    Depreciation & Amortization
    		 6.55M 2.85M 1.86M 1.22M
    Stock-Based Compensation
    		 116.01M 82.47M 51.97M 26.18M
    Other Working Capital
    		 10.52M 2.14M 9.13M 6.36M
    Other Non-Cash Items
    		 -8.11M 1.27M 812K 1.37M
    Deferred Income Tax
    		 n/a n/a n/a 14K
    Change in Working Capital
    		 -37.71M -40.78M 1.81M -6.86M
    Operating Cash Flow
    		 130.25M 24.65M 11.57M -20.12M
    Capital Expenditures
    		 -39.12M -23.63M -9.1M -4.67M
    Cash Acquisitions
    		 n/a n/a n/a -33.81M
    Purchase of Investments
    		 -418.6M -281.44M -10.5M -9.99M
    Sales Maturities Of Investments
    		 344.61M 10.25M n/a 43.8M
    Other Investing Acitivies
    		 n/a n/a -10.5M 33.81M
    Investing Cash Flow
    		 -113.12M -294.82M -19.6M 29.14M
    Debt Repayment
    		 n/a n/a -24.5M n/a
    Common Stock Repurchased
    		 -75M -17.16M n/a 3.47M
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 22.61M 13.95M 15.78M 14.95M
    Financial Cash Flow
    		 -52.39M 13.95M 235.08M 14.95M
    Net Cash Flow
    		 -35.39M -256.06M 227.13M 23.95M
    Free Cash Flow
    		 91.12M 1.02M 2.47M -24.79M

    Add to Watchlist